Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
Filing tables
Filing exhibits
- 10-K Annual report
- 4.4 Description of Securities Registered Under Section 12
- 10.8 Form of Intec Pharma LTD. Grant Letter - Section 102
- 10.9 Form of Intec Pharma LTD. 2015 Equity Incentive Plan Notice of Non-qualified Stock Option Award
- 23.1 Consent of Kesselman & Kesselman, Certified Public Accountant (Isr.), Independent Registered Public Accounting Firm, a Member of Pricewaterhousecoopers International Limited
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
Related press release
Indaptus Therapeutics similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-230016) and S-8 (No. 333-227027, No. 333-222217, No. 333-209700 and No. 333-212801) of Intec Pharma Ltd. of our report dated March 13, 2020 relating to the financial statements, which appears in this Form 10-K.
Tel-Aviv, Israel | /s/ Kesselman & Kesselman | |
March 13, 2020 | Certified Public Accountants (Isr.) | |
A member firm of PricewaterhouseCoopers International Limited |
Kesselman & Kesselman, Trade Tower, 25 Hamered Street, Tel-Aviv 6812508, Israel,
P.O Box 50005 Tel-Aviv 6150001 Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.com/il